Episode Overview

Podcast: The MSing Link
Host: Dr. Gretchen Hawley, PT, DPT, MSCS
Guest: Dr. Kelly Rich, Neuroscientist, Harvard Medical School
Episode: 270. Does MS Affect Brain Aging? What the Research Shows
Release: February 4, 2026

This episode explores the intersection of multiple sclerosis (MS) and brain aging, with a focus on cutting-edge research by Dr. Kelly Rich of the Sinclair Lab at Harvard. The conversation delves into how MS and traditional aging processes overlap, recent advances in cellular reprogramming, the realistic role of lifestyle interventions, and how the pace of scientific progress can be both challenging and hopeful.

Key Discussion Points & Insights

1. Dr. Kelly Rich’s Background and Research Focus [(04:40-05:42)]

• Dr. Rich explains her background in clinical genetic counseling and neuroscience, emphasizing her research on how aging alters the nervous system at a cellular level and how targeting aging biology may benefit neurodegenerative diseases, including MS.
• "My little corner [in the Sinclair lab] is studying how aging changes the nervous system at a cellular level and how targeting aging biology might help treat neurological diseases, one or many." – Dr. Kelly Rich [04:53]

2. Is MS Just ‘More Aging’ or Something Different? [(05:42-09:14)]

• MS is not separate from aging—many changes in MS mirror those of accelerated brain aging (e.g., reduced energy use, slower repair, increased inflammation).
• Dr. Rich emphasizes the idea of biological age vs. chronological age, noting that cells affected by MS may act “older” than expected given someone’s calendar age.
• "Disease and aging, we're starting to think of them as a little bit more of overlapping processes. And that certainly applies to a disease like MS." – Dr. Kelly Rich [07:55]

3. Traditional Approaches vs. the Aging Lens [(09:14-12:04)]

• Instead of chasing downstream symptoms (e.g., demyelination, inflammation), there's value in targeting the underlying aging processes that lower neurons' margin for error.
• Dr. Rich describes disease as “cell-specific premature aging,” and notes that evidence suggests people with MS display features of accelerated biological aging.
• "Instead of treating the obvious symptoms downstream, we also ask, what would it take to take those cells and put them back into a more youthful and resilient state?" – Dr. Kelly Rich [11:24]

4. Cellular Reprogramming: Resetting Cellular Age [(12:39-15:22)]

• Cellular reprogramming aims to “refresh” cells, using genes known as Yamanaka factors, without erasing their identity (e.g., keeping neurons as neurons).
• Dr. Rich likens this to a “software update,” not a full factory reset.
• "We use something called partial reprogramming...the goal here is [to repair] damage brought on by aging or disease without changing the cell's identity." – Dr. Kelly Rich [13:37]
• These strategies have shown promise in treating eye diseases, dementia, and wound healing in animal models.

5. From Lab to Clinic: How Close Are We? [(15:22-19:05, 32:21-33:16)]

• Translation from animal studies to human therapies is occurring, but each disease (like MS) requires extensive safety and efficacy testing.
• Viral vectors (gene therapy) are used in proof-of-concept studies, but the lab is working to develop more accessible “pill-based” approaches that mimic these cellular effects.
• Early interventions, such as those for eye diseases, could reach human clinical trials within 2-3 years.
• "In some ways, we are very close in certain conditions. But...there is a long road ahead. That's exciting, right?" – Dr. Kelly Rich [15:42]
• "I can certainly imagine it will be in humans within the next two or three years." – Dr. Kelly Rich [32:47]

6. What About MS Specifically? [(21:41-24:37)]

• Recent studies in mouse models of MS using cellular reprogramming show improved neuronal survival and function, suggesting potential future avenues for MS care.
• Such strategies are disease-agnostic, aiming to restore resilience and function broadly rather than treating symptoms in isolation.
• "These cells that are implicated start to behave like they're older than the rest of the body...So instead of treating the obvious symptoms...we also ask, what would it take to take those cells and put them back into a more youthful and resilient state?" – Dr. Kelly Rich [10:36; see also 22:12]

7. Lifestyle Interventions: Do They Really Matter? [(26:33-29:07)]

• Despite hype around supplements like NAD precursors (NR, NMN), large-scale studies still emphasize the value of the “boring basics”:
  • Cardiovascular health (blood pressure, cholesterol)
  • Exercise (aerobic and strength)
  • Good sleep and stress management
  • Social and cognitive engagement
• "From an aging biology perspective, the boring basics are really what matter the most for brain health." – Dr. Kelly Rich [27:15]
• Lab supplements are promising in mice and cells but not yet substantiated for long-term brain health.

8. NAD and Its Hype in MS [(30:01-31:37)]

• NAD is crucial for cell energy and repair, and levels decline with age and disease. The appeal is the theoretical ease of boosting NAD with supplements, but clinical effectiveness for MS remains unproven.
• "What we know is that in disease and aging states, NAD tends to decline...Can we try to change and supplement something that we know is declining in aging?" – Dr. Kelly Rich [30:33]

9. The Researcher’s Perspective: Progress, Disappointments, and Hope [(33:16-40:24)]

• Dr. Rich highlights the importance of slow, careful, and independent academic science.
• The scientific process is fundamentally uncertain and iterative, but newer technologies are accelerating meaningful breakthroughs.
• Disappointing clinical trial results fuel further research; failures provide critical lessons for future success.
• "Academic science exists...without a predetermined outcome and without like the commercial pressure of...maximiz[ing] profits for shareholders. This independence is really critical." – Dr. Kelly Rich [34:16]
• "We ask questions that can only lead to more questions...it's on us as scientists to stand on the shoulders of the scientists who came before us." – Dr. Kelly Rich [38:07]
• "Even though this has been a very tough year for science, I've never been more hopeful about the state of science." – Dr. Kelly Rich [40:24]

10. Staying Updated with the Sinclair Lab [(40:47-41:28)]

• Follow the Sinclair Lab on Instagram for behind-the-scenes updates
• Dr. Kelly Rich’s own Instagram: @kellyrichphd
• The Lifespan podcast by Dr. David Sinclair is recommended for in-depth discussions on aging and brain health

Notable Quotes & Memorable Moments

• On the Basics:
  "From an aging biology perspective, the boring basics are really what matter the most for brain health."
  – Dr. Kelly Rich [27:15]

• On Hope in Science:
  "Even though this has been a very tough year for science, I've never been more hopeful about the state of science."
  – Dr. Kelly Rich [40:24]

• On Research Mindset:
  "We have to be transparent...not dampening excitement and not, like, placating disappointment, but channeling the interest in a realistic and useful way."
  – Dr. Kelly Rich [39:42]

Key Timestamps for Major Segments

| Segment | Time | |-----------------------------------------------------|--------------| | Introduction and Dr. Rich’s Background | 00:00-05:42 | | MS & Aging: Are They Connected? | 05:42-09:14 | | Biological Aging vs. Chronological Age in MS | 09:14-12:04 | | Cellular Reprogramming Explained | 12:39-15:22 | | From Animal Models to Human Therapies | 15:22-19:05 | | Application for MS | 21:41-24:37 | | Lifestyle Interventions vs. Supplements | 26:33-29:07 | | NAD, NR, NMN: Hope or Hype? | 30:01-31:37 | | Realistic Timeline for New Therapies | 32:21-33:16 | | The Reality of Scientific Discovery | 33:16-40:24 | | How Listeners Can Stay Informed | 40:47-41:28 |

Final Takeaways

• MS and brain aging are deeply intertwined at the cellular level.
• Targeting aging processes, rather than just symptoms, could revolutionize treatment approaches for MS and other neurodegenerative diseases.
• Cellular reprogramming and other molecular strategies are progressing from promising lab work toward early-stage clinical translation, with therapies for some conditions potentially just a few years away.
• Lifestyle basics matter: best current evidence still supports exercise, cardiovascular health, and social engagement for brain longevity.
• **The pace of science can frustrate and inspire, but each step—positive or negative—moves the field closer to more effective, broader, and more personalized strategies for MS and brain aging.

For ongoing updates:

• Sinclair Lab on Instagram
• Dr. Kelly Rich on Instagram: @kellyrichphd
• Dr. David Sinclair’s Lifespan podcast

(This summary omits advertisements, sponsorships, and general podcast housekeeping, focusing strictly on research discussion and actionable insights.)